PL4124336T3 - Plaster przezśluzówkowy obejmujący kannabinoid i/lub opioid - Google Patents
Plaster przezśluzówkowy obejmujący kannabinoid i/lub opioidInfo
- Publication number
- PL4124336T3 PL4124336T3 PL21188925.8T PL21188925T PL4124336T3 PL 4124336 T3 PL4124336 T3 PL 4124336T3 PL 21188925 T PL21188925 T PL 21188925T PL 4124336 T3 PL4124336 T3 PL 4124336T3
- Authority
- PL
- Poland
- Prior art keywords
- cannabinoid
- opioid
- transmucosal patch
- transmucosal
- patch
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21188925.8A EP4124336B1 (en) | 2021-07-30 | 2021-07-30 | Transmucosal patch comprising a cannabinoid and/or an opioid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL4124336T3 true PL4124336T3 (pl) | 2024-02-26 |
Family
ID=77168007
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL21188925.8T PL4124336T3 (pl) | 2021-07-30 | 2021-07-30 | Plaster przezśluzówkowy obejmujący kannabinoid i/lub opioid |
| PL22757589.1T PL4376817T3 (pl) | 2021-07-30 | 2022-07-29 | Plaster przezśluzówkowy zawierający kannabinoid i/lub opioid |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL22757589.1T PL4376817T3 (pl) | 2021-07-30 | 2022-07-29 | Plaster przezśluzówkowy zawierający kannabinoid i/lub opioid |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250041240A1 (pl) |
| EP (2) | EP4124336B1 (pl) |
| JP (1) | JP2024527960A (pl) |
| KR (1) | KR20240070510A (pl) |
| CN (1) | CN118076344A (pl) |
| AU (1) | AU2022318169A1 (pl) |
| CA (1) | CA3226305A1 (pl) |
| ES (2) | ES2962999T3 (pl) |
| IL (1) | IL310490A (pl) |
| PL (2) | PL4124336T3 (pl) |
| WO (1) | WO2023006980A1 (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024160792A1 (en) * | 2023-01-30 | 2024-08-08 | Cannamedical Pharma Gmbh | Improved transmucosal patch comprising a cannabinoid and/or an opioid |
| DK202330231A1 (en) * | 2023-09-27 | 2025-04-10 | Fertin Pharma As | Cannabidiol for alleviating xerostomia |
| WO2025065065A1 (en) * | 2023-09-30 | 2025-04-03 | Encap Hive Pty Ltd | Nanofibrous dermal mat, transdermal patches, dressings and dermatological products including same |
| WO2025147721A1 (en) * | 2024-01-05 | 2025-07-10 | Keylika, Inc. | Patch for transmucosal drug delivery |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL80411A (en) | 1986-10-24 | 1991-08-16 | Raphael Mechoulam | Preparation of dibenzopyranol derivatives and pharmaceutical compositions containing them |
| DE4100441A1 (de) | 1991-01-09 | 1992-07-16 | Mack Chem Pharm | Verfahren zur herstellung von 6,12-dihydro-6-hydroxy-cannabidiol und dessen verwendung zur herstellung von trans-delta-9-tetrahydrocannabinol |
| US5434295A (en) | 1994-02-07 | 1995-07-18 | Yissum Research Development Company | Neuroprotective pharmaceutical compositions of 4-phenylpinene derivatives and certain novel 4-phenylpinene compounds |
| AU6111796A (en) | 1995-06-12 | 1997-01-09 | G.D. Searle & Co. | Compositions comprising a cyclooxygenase-2 inhibitor and a 5 -lipoxygenase inhibitor |
| GB0202385D0 (en) | 2002-02-01 | 2002-03-20 | Gw Pharma Ltd | Compositions for the treatment of nausea,vomiting,emesis,motion sicknes or like conditions |
| GB2414933B (en) | 2004-06-08 | 2009-07-15 | Gw Pharma Ltd | Cannabinoid compositions for the treatment of disease and/or symptoms in arthritis |
| TWI366460B (en) | 2005-06-16 | 2012-06-21 | Euro Celtique Sa | Cannabinoid active pharmaceutical ingredient for improved dosage forms |
| DK3154513T3 (da) * | 2014-06-10 | 2020-01-27 | Afyx Therapeutics As | Sammensætninger, der omfatter elektrohydrodynamisk opnåede fibre til administration af specifikke doseringer af en aktiv substans til hud eller slimhinde |
| AU2015292915B2 (en) | 2014-07-21 | 2020-10-15 | Pharmaceutical Productions, Inc. | Solid dosage form composition for buccal or sublingual administration of cannabinoids |
| JP6606279B2 (ja) * | 2015-11-19 | 2019-11-13 | エーエフワイエックス・セラピューティクス・エー／エス | 適用部位における滞留時間が改善された、電気流体力学的に得られた繊維を含む医薬組成物 |
| WO2018071452A1 (en) | 2016-10-11 | 2018-04-19 | Growblox Life Sciences L.L.C. | Cannabinoid-containing complex mixtures for the treatment of neurodegenerative diseases |
| CA3063613A1 (en) * | 2017-05-13 | 2018-11-22 | Alvit Lcs Pharma Ltd. | Sublingual cannabinoid compositions |
| EP3641726B1 (en) | 2017-06-23 | 2025-11-05 | NordicCan A/S | Cannabinoid pouch |
| ES2986969T3 (es) | 2017-06-23 | 2024-11-13 | Nordiccan As | Bolsita con cannabinoides |
| JP2021500312A (ja) | 2017-09-15 | 2021-01-07 | ゼルダ セラピューティクス オペレーションズ ピーティーワイ リミテッド | 自閉症の治療のための組成物および方法 |
-
2021
- 2021-07-30 EP EP21188925.8A patent/EP4124336B1/en active Active
- 2021-07-30 PL PL21188925.8T patent/PL4124336T3/pl unknown
- 2021-07-30 ES ES21188925T patent/ES2962999T3/es active Active
-
2022
- 2022-07-29 ES ES22757589T patent/ES3042646T3/es active Active
- 2022-07-29 EP EP22757589.1A patent/EP4376817B1/en active Active
- 2022-07-29 AU AU2022318169A patent/AU2022318169A1/en active Pending
- 2022-07-29 CN CN202280052353.9A patent/CN118076344A/zh active Pending
- 2022-07-29 IL IL310490A patent/IL310490A/en unknown
- 2022-07-29 CA CA3226305A patent/CA3226305A1/en active Pending
- 2022-07-29 JP JP2024504932A patent/JP2024527960A/ja active Pending
- 2022-07-29 KR KR1020247006464A patent/KR20240070510A/ko active Pending
- 2022-07-29 PL PL22757589.1T patent/PL4376817T3/pl unknown
- 2022-07-29 US US18/291,837 patent/US20250041240A1/en active Pending
- 2022-07-29 WO PCT/EP2022/071416 patent/WO2023006980A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| CA3226305A1 (en) | 2023-02-02 |
| US20250041240A1 (en) | 2025-02-06 |
| IL310490A (en) | 2024-03-01 |
| ES2962999T3 (es) | 2024-03-22 |
| EP4124336C0 (en) | 2023-10-25 |
| EP4124336A1 (en) | 2023-02-01 |
| CN118076344A (zh) | 2024-05-24 |
| EP4376817A1 (en) | 2024-06-05 |
| AU2022318169A1 (en) | 2024-01-25 |
| KR20240070510A (ko) | 2024-05-21 |
| PL4376817T3 (pl) | 2025-11-24 |
| WO2023006980A1 (en) | 2023-02-02 |
| JP2024527960A (ja) | 2024-07-26 |
| ES3042646T3 (en) | 2025-11-24 |
| EP4376817C0 (en) | 2025-07-02 |
| EP4376817B1 (en) | 2025-07-02 |
| EP4124336B1 (en) | 2023-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL310490A (en) | A transmucosal patch that includes cannabinoids and/or an opioid | |
| EP3926935C0 (en) | ANTENNA AND ELECTRONIC DEVICE COMPRISING SAME | |
| MY156819A (en) | Integrated ingestible event marker system with pharmaceutical product | |
| IL298198B2 (en) | Identification of transient events | |
| EP4175063A4 (en) | ANTENNAS AND ELECTRONIC DEVICE INCLUDING SAME | |
| EP4145630A4 (en) | DUAL POLARIZED MULTI-FREQUENCY ANTENNA AND ELECTRONIC DEVICE | |
| ES3048798T3 (en) | Antenna unit and electronic device | |
| EP4246715A4 (en) | ANTENNA AND ELECTRONIC DEVICE THEREFOR | |
| GB202000221D0 (en) | Electronic aerosol provision system | |
| EP4123828A4 (en) | ANTENNA UNIT AND ELECTRONIC DEVICE | |
| CA195601S (en) | Microneedling patch | |
| EP4398415A4 (en) | ANTENNA AND ELECTRONIC DEVICE THEREFOR | |
| EP4404377A4 (en) | ANTENNA AND ELECTRONIC DEVICE COMPRISING IT | |
| EP4354655A4 (en) | ANTENNA STRUCTURE AND ELECTRONIC DEVICE | |
| PL3428696T3 (pl) | Odblaskowy materiał kompozytowy, w szczególności do elementów konstrukcyjnych montowanych powierzchniowo (smd) oraz urządzenie emitujące światło z takim materiałem kompozytowym | |
| GB201914947D0 (en) | Electronic aerosol provision system and method | |
| EP4184718A4 (en) | ANTENNA DEVICE AND ELECTRONIC DEVICE THEREOF | |
| GB202018721D0 (en) | Electronic Aerosol Provision System | |
| GB202003961D0 (en) | Electronic aerosol provision system | |
| IL314099A (en) | Monitoring patch | |
| GB202217891D0 (en) | Antenna monitoring and selection | |
| GB201914945D0 (en) | Electronic aerosol provision system and method | |
| EP4325821A4 (en) | ELECTRONIC DEVICE WITH ANTENNA AND MICROPHONE | |
| EP4418455A4 (en) | ANTENNA AND ELECTRONIC DEVICE THEREFOR | |
| EP4290690A4 (en) | ANTENNA AND ELECTRONIC DEVICE THEREFOR |